Background. Baseline 2-step tuberculin skin testing (TST) is recommended for health care workers (HCWs) to identify cases of the "boosting phenomenon" (i.e., a negative initial TST result followed by a positive result) and to track the risk of acquiring occupational tuberculosis. However, the 2-step TST has been shown to be insufficient to identify all cases of the booster phenomenon in older adults and refugees. The objective of this study was to identify whether a history of bacille Calmette-Guérin (BCG) vaccination and foreign birth-variables that are known to be associated with the booster phenomenon-remain predictors of a positive TST result in a group of HCWs documented to have negative 2-step TST results (i.e., 2 TSTs done 7-28 days apart with indurations !10 mm in diameter).
Because of the increased risk for acquiring occupational
Mycobacterium tuberculosis infection [1] [2] [3] [4] , regular surveillance of health care workers (HCWs) has been recommended [1, 3] . The 2-step tuberculin skin test (TST) is an important part of tuberculosis surveillance programs [1, 3] . In the 2-step TST, a second test is done 1-4 weeks after the first, to identify those who have immunologic recall of the tuberculosis antigen [5] . A positive result after an initial negative result is referred to as the "booster phenomenon." The results of the second test are then taken as the baseline with which to compare future TST results. A subsequent positive TST result after a negative 2-step TST result is assumed to represent a conversion, and treatment of latent tuberculosis may be recommended [1, 3] . Treatment of latent tuberculosis is not without risk [6] [7] [8] [9] , and giving antituberculosis medications to adults who have not experienced recent TST conversion is not recommended by some authorities [10] .
Birth in a country in which there is a high risk for tuberculosis and history of bacille Calmette-Guérin (BCG) vaccination are factors that have been repeatedly associated with the boosting phenomenon [11] [12] [13] . The question of whether the 2-step TST is sufficient to identify the boosting phenomenon has been raised [14] [15] [16] . Delayed boosting was also postulated as a possible cause of high TST conversion rates among foreign-born HCWs in the United States [17] .
The purpose of this study was to identify predictors of a positive TST result in a group of Canadian HCWs with negative 2-step TST results. Given the low prevalence of tuberculosis in Canada [18] , we hypothesized that, if foreign birth and history of BCG vaccination predicted a subsequent positive TST result for HCWs with a negative 2-step TST result, then some positive TST results among these HCWs could be due to the booster phenomenon and not to recent occupational contact. This information would aid in decisions regarding treatment of latent tuberculosis in such HCWs.
METHODS
The staff occupational health records of a tertiary care hospital in Winnipeg, Canada, were used in this study. Of the ∼15,000 annual admissions to this hospital, ∼100 are for treatment of tuberculosis. Occupational health nurses perform annual surveillance in high-risk work areas and follow-up contacts of patients with tuberculosis who were admitted to the ward and not isolated before diagnosis.
The TST involves intradermal injection of 0.1 mL (5 tuberculin units) of purified protein derivative (Tubersol; Connaught Laboratories) into the anterior surface of the forearm with a standard tuberculin syringe. Reactions were read 48-72 h after the injection, and the transverse diameter of the area of induration was recorded in millimeters [1] . A 10-mm induration was considered to be a positive result [1] . A 2-step TST result was defined as negative when 2 TSTs done 7-28 days apart both had reactions with indurations !10 mm. A TST conversion was defined as a reaction of 110 mm that was у6 mm larger than the baseline TST result [1, [14] [15] [16] 19] . A second definition of conversion-a second TST result that was у10 mm larger than the baseline reaction [3, 17] -was also used. Unless otherwise stated, results refer to the first definition of conversion.
The employee database contains records of 10,509 HCWs employed during 1993-2002. Review of the staff records identified 698 persons who had negative 2-step TST results and had a subsequent TST performed within 2 years after completion of the 2-step test. The 2-year period was selected because it is the period of greatest likelihood of developing active tuberculosis following conversion, and "new converters" during this period are often offered therapy [1, 3] .
Employee records were reviewed, and information on dates and sizes of TST reactions, history of BCG vaccination, date of birth, sex, hospital department, and country of birth was abstracted. BCG vaccination status was determined by both history (based on self report and/or immunization records) and identification of scars. Information on country of birth was initially not available for 391 HCWs, all of whom had negative results of the follow-up (i.e., third) TST. A mailed survey and chart review identified country of birth information for 235 of these persons; 20 (8.5%) were born outside of Canada. Given this finding, the HCWs whose country of birth was unknown were grouped together with the Canadian-born HCWs for analyses. Seventy-one of the 101 foreign-born subjects were born in countries in Southeast Asia, the Western Pacific, Africa, and the Americas in which there is a higher risk of tuberculosis.
Hospital departments were divided into those thought to have the highest risk for contact with patients with tuberculosis and those thought to have a lower risk. The high-risk work settings included the medical intensive care unit; the medical, respiratory, and emergency wards; the microbiology and pathology laboratories; and the radiology department. HCWs who worked continuously in these areas were deemed to work in a high-risk setting. HCWs who worked in these areas for some but not all of their workday and were members of other departments (e.g., social workers and physicians) were grouped with HCWs who worked in the lower-risk settings.
Person-time of follow-up was calculated as the interval between the second step of the 2-step test and the follow-up TST. Yearly conversion rates were calculated to standardize for the differing follow-up durations. Because of the association between positive TST reactions and both foreign birth and history of BCG vaccination, these variables were combined to create 4 mutually exclusive possibilities: history of BCG vaccination and foreign-born, history of BCG vaccination and Canadian born, no history of BCG vaccination and foreign-born, and no history of BCG vaccination and Canadian born. Conversion rates were compared for the BCG/country of birth groups for the entire cohort and by department work setting.
Data were analyzed with SPSS 11.0 statistical software (SPSS). Bivariate analyses were done with x 2 tests and Student's t tests for categorical and continuous data, respectively. was P ! .05 considered to be significant. Multiple logistic regression analysis was used to identify the predictors of conversion reactions. ORs and 95% CIs were calculated to measure the association between predictors and conversion reaction.
RESULTS
Of the 698 HCWs who had negative 2-step TST results, 46 (6.6%) had TST conversion when follow-up testing was done within 2 years after the baseline result. The number of HCWs with conversion decreased to 34 (4.9%) when the second definition of conversion was used. Table 1 compares HCWs who converted with those who did not with respect to a number of demographic and occupational variables. HCWs with TST conversion were more likely to have a history of BCG vaccination, to be foreign-born, and to work in higher-risk departments. Similar results were observed when a more restrictive definition of a positive test result (у15-mm induration) was used (data not shown). Table 2 describes the results of a multiple logistic regression analysis that controlled for the effects of age at the time of the most recent TST (!35 or у35 years), sex, history of BCG vaccination, country of birth, and higher-risk department. Elevated adjusted ORs were observed for higher-risk department, history of BCG vaccination, and foreign birth. Repeat analysis, in which time since the 2-step TST (1-2 years vs. !1 year) replaced age in the logistic regression analysis, found no association between the time since the 2-step TST and conversion (OR, 1.24; 95% CI, 0.62-2.48). The annual conversion rate for the entire cohort was 6.5% (95% CI, 6.3%-6.8%) (table 3). When conversion rates were compared for the various BCG and foreign birth groupings, an 18-fold difference was observed between the rates. The group with a history of BCG vaccination and foreign birth had an annual conversion rate of 36.0% (95% CI, 30.7%-43.4%), whereas the group with no history of BCG vaccination and Canadian birth had an annual conversion rate of 2.0% (95% CI, 1.9%-2.1%). Similar differences were observed when the more restrictive definition of conversion was used, although the conversion rates were lower. If the entire cohort had conversion rates similar to the group with no history of BCG and Canadian birth, we estimated that 18% of the rest of the cohort had unexpected conversions.
The cohort was stratified into higher-and lower-risk departments (table 4) . In this analysis, the groups with history of BCG vaccination and foreign birth were grouped together because of small numbers in some cells. These results revealed higher conversion rates in the combined BCG and foreignborn groups in both the higher-and lower-risk departments.
Clinical review and chest radiography of the 46 HCWs with a positive TST result did not identify any HCW with suspected active tuberculosis. The pros and cons of treatment for latent tuberculosis were discussed with the HCWs, and 13 elected to proceed with treatment. No HCW with TST conversion subsequently received a diagnosis of active tuberculosis. 
DISCUSSION
This study revealed that, even among persons who had a negative 2-step TST result, history of BCG vaccination and foreign birth remained strong predictors of TST conversion within 2 years after the baseline result. These results were found after controlling for age, sex, time between tests, and work department and were not influenced by the definition of TST conversion used (table 3) . There are a number of possible explanations for our findings. First, foreign-born persons or those who had BCG vaccinations may be more likely to associate with persons at risk for tuberculosis and could be exposed to tuberculosis on a nonoccupational basis. None of the HCWs with positive TST results, however, reported a nonoccupational contact. To further investigate this possibility, we provided the provincial tuberculosis registry with a list of the HCWs with positive TST results. The registry reported that none of these HCWs were contacts of individuals in the community who were known to have tuberculosis.
Although many of the First Nations (aboriginal) population in Canada receive BCG vaccination, the vast majority of the Canadian-born persons in our cohort who had received BCG vaccination were HCWs who received the vaccine when they entered their profession. As a group, they would be less likely to associate nonoccupationally with people at high risk for tuberculosis in the community. For these reasons, we believe that nonoccupational contact in Canada, a country in which there is a low risk for community spread of tuberculosis [18] , is an unlikely explanation for all of the observed excess conversions.
Differential travel history to countries at higher risk of tuberculosis could also explain our results. We do not have detailed travel histories for HCWs with negative TST results. Among those with positive results, only 3 HCWs, including 1 who was Canadian-born without a history of BCG vaccination, had documented travel outside of North America between their 2-step test and the subsequent positive TST result. Thus, travel to high-risk countries is an unlikely explanation of our findings.
Another possibility is that we did not fully control for occupational factors, such as ventilation [20] or the impact of delayed or missed diagnosis of tuberculosis [21] , and that foreign-born HCWs or HCWs with BCG vaccination were more likely to have occupational exposure than were those who were Canadian-born without a history of BCG vaccination. Our stratified analysis argues against this explanation, because Canadian-born HCWs without BCG vaccination had significantly lower conversion rates than did HCWs in the other groups in both the higher-and lower-risk work departments (table 4) .
We believe that delayed boosting must be considered an explanation of our findings, because history of BCG vaccination and foreign birth, both of which have been strongly associated with boosting between the first and second tests in a 2-step TST [11] [12] [13] , were identified as strong predictors of TST conversion. Thus, it is not unreasonable to assume that the second test in the 2-step TST was not sufficient to boost immunologic recall and that the follow-up TST was. In 2 studies of HCWs with negative 2-step TST results, history of BCG vaccination [17, 22] and foreign birth [17] were also found to be strongly associated with a third positive TST result.
The incidence of boosting after the third TST has been reported to be 7.3% in a population in a chronic care facility [16] , 18% among older persons [15] , and 30.5% among IndoChinese refugees [14] . If the unexpected conversions in our study are assumed to be due to boosting, then the delayed boosting rate of 18% we observed is consistent with these reports.
Time between the 2-step TST and the follow-up TST was not associated with a positive TST result. Although the booster phenomenon had been reported to explain conversion for up to 1 year after the 2-step TST [5] , our results suggest that it could last for at least 2 years. The size of the TST reaction did not help differentiate HCWs with conversion from those with boosting in our study, because similar results were found with all of the definitions of a positive result that were used.
Our study has a number of limitations. For ∼22% of the cohort, all of whom had negative 2-step TST results, information regarding country of birth was missing. These subjects were grouped with the Canadian-born HCWs. In the initial evaluation, 16.3% of the HCWs for whom the country of birth was known and who had negative TST results were foreignborn. Foreign birth was subsequently identified for 20 (8.5%) of the 235 subjects for whom we obtained additional information. It is likely that 8.5%-16.3% of the 156 individuals whose country of birth was unknown were foreign born. Because of this low number, we accepted this source of bias and included the HCWs for whom the country of birth was unknown in the analyses. Exclusion of this group from the analysis, however, did not change the results of the logistic regression, although the OR for foreign birth decreased to 2.24 (95% CI, 1.08-4.66).
A second limitation is that our definition of higher-risk departments may not be generalizable to other hospitals in Canada and other countries. Third, our sample group was not random. The cohort consisted only of HCWs with negative 2-step TST results who had a third TST performed within 2 years. Although this may have affected the conversion rates, we do not believe that this influenced the association we observed between country of birth or BCG vaccination and positive results of a third TST. Finally, because we did not perform the serial TST tests over a short time, we cannot definitively rule out differential recent exposure to tuberculosis as the cause of our findings.
Our results suggest that the 2-step TST may not be sufficient to identify the booster response in HCWs. We encourage other researchers to attempt to replicate our findings. Foreign-born HCWs or those with a history of BCG vaccination who had a positive follow-up TST result after having a negative 2-step TST result may still have positive results because of the booster phenomenon. Our results suggest that physicians cannot rely on the 2-step TST to distinguish new conversion from boosting in the interpretation of TST results for HCWs at risk for boosting. Until alternative modes of diagnosing latent tuberculosis become readily available and accepted, physicians will have to base their recommendations for treating latent tuberculosis in such HCWs on a number of factors. These include the likelihood of recent significant contact with tuberculosis, the risks to the individual for both the development of active tuberculosis and the side effects of treatment, and the HCW's preferences regarding treatment.
